Cargando…
Cost-effectiveness of precision molecular diagnostic tests for stage II colorectal cancer
BACKGROUND: In colorectal cancer, inappropriate use of adjuvant chemotherapies may lead to significant increases in healthcare costs and harms to patients. Genome-based interventions are being increasingly used in the stratification of patients according to their risk profiles. However, earlier cost...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816824/ https://www.ncbi.nlm.nih.gov/pubmed/36618812 http://dx.doi.org/10.21037/atm-2022-77 |